Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

Ottawa Hospital Research Institute

$856,800.00

Regulating the Functions of Human Liver Sinusoidal Endothelial Cells to Fight Liver Disease

EF 2023-24

Résumé
Over 100 liver diseases collectively impact 1 in 4 Canadians, and this costly burden grows yearly. In many liver diseases, the endothelial cells that form the inner lining of blood vessels lose special functions needed to sustain the organ's 500+ life supporting tasks. Unfortunately, little is known about what keeps liver endothelium working properly. This proposal will leverage pluripotent stem cells, which can become any of the body's cells, to make liver endothelium and study how these cells gain and keep their unique functions. This work will equitably train diverse and highly skilled Canadians as "Cell Therapists" to guide damaged liver endothelium back to health with new therapies or replace damaged cells completely, revitalizing the liver. In the proposed work, we will guide these pluripotent stem cells to become special endothelial cells which, once injected into mice, can live, grow, and mature in the liver. Within the liver, these cells become fully functional liver endothelium that, with careful characterization, will teach us how this maturation process occurs. The proposed studies will build a map of how each function of the liver endothelial cells develops and the order of signals that impart each function. This knowledge will give new treatments and hope for patients with acute and chronic liver diseases as well as liver cancer and Hemophilia A. With life and health span improvements for patients, Canada will benefit from reduced healthcare costs and socioeconomic burdens as the proposed cell-informed and cell-based therapies mobilize private sector partners and move into the clinic.
Programme
Project Grant
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
500056
Name
Gage Blair K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - C: Vascular System
Projecttitle
Regulating the Functions of Human Liver Sinusoidal Endothelial Cells to Fight Liver Disease
Programtype2
Operating Grants
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$856,800
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cell Therapy; Crispr/Cas9; Endothelial Functions; Functional Genetics; Hemophilia A; Human Pluripotent Stem Cells; Humanized Mouse Models; Liver Disease; Liver Sinusoidal Endothelial Cells; Vascular Homeostasis
Abstract
Over 100 liver diseases collectively impact 1 in 4 Canadians, and this costly burden grows yearly. In many liver diseases, the endothelial cells that form the inner lining of blood vessels lose special functions needed to sustain the organ's 500+ life supporting tasks. Unfortunately, little is known about what keeps liver endothelium working properly. This proposal will leverage pluripotent stem cells, which can become any of the body's cells, to make liver endothelium and study how these cells gain and keep their unique functions. This work will equitably train diverse and highly skilled Canadians as "Cell Therapists" to guide damaged liver endothelium back to health with new therapies or replace damaged cells completely, revitalizing the liver. In the proposed work, we will guide these pluripotent stem cells to become special endothelial cells which, once injected into mice, can live, grow, and mature in the liver. Within the liver, these cells become fully functional liver endothelium that, with careful characterization, will teach us how this maturation process occurs. The proposed studies will build a map of how each function of the liver endothelial cells develops and the order of signals that impart each function. This knowledge will give new treatments and hope for patients with acute and chronic liver diseases as well as liver cancer and Hemophilia A. With life and health span improvements for patients, Canada will benefit from reduced healthcare costs and socioeconomic burdens as the proposed cell-informed and cell-based therapies mobilize private sector partners and move into the clinic.
Competitiondate
202403
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Gage, Blair K
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $856,800~ $0~